A critical advance in cancer investigation is arising with the use of VHH fragments to re-engage damaged p53. This vital tumor inhibitor protein is frequently disabled in several forms of cancer, causing uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research